MARKET

IQV

IQV

Iqvia Hldgs Inc
NYSE
216.91
+2.81
+1.31%
After Hours: 216.91 0 0.00% 16:23 12/01 EST
OPEN
214.00
PREV CLOSE
214.10
HIGH
217.26
LOW
211.99
VOLUME
1.20M
TURNOVER
0
52 WEEK HIGH
241.86
52 WEEK LOW
167.42
MARKET CAP
39.59B
P/E (TTM)
36.39
1D
5D
1M
3M
1Y
5Y
Iqvia Hldgs Inc: Report of proposed sale of securities
Press release · 2d ago
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)
TipRanks · 3d ago
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q3 2023 Update
Duquesne family office's 13f portfolio value decreased by 3% to $2.79b in q3 2023. The largest five stakes are nvidia, coupang, microsoft, eli lilly, and teck resources. New stakes include alphabet, vistra corp, seagate tech, and broadcom.
Seeking Alpha · 3d ago
Looking Into IQVIA Hldgs's Recent Short Interest
Iqvia hldgs's short percent of float has risen 32.98% since its last report. The company has 4.05 million shares sold short, 2.54% of all regular shares. Short interest is the number of shares that have been sold short but not yet covered.
Benzinga · 3d ago
Veeva Systems Q3 Preview: Navigating Challenges And Opportunities For F2025
Veeva systems inc. Stock is well-positioned with lower expectations as it prepares to report its fiscal q3 2024 results. Veeva is expected to report fiscal 2024 results post-market on 6 december 2023. I believe paying 26x forward free cash flows is now a better entry point for investors. The company is transitioning from its fiscal year 2024 to fiscal 2025.
Seeking Alpha · 4d ago
Iqvia Hldgs Inc: Current report
Press release · 5d ago
Price Over Earnings Overview: IQVIA Hldgs
Iqvia hldgs inc. Shares are trading at $212.73 in the current session. Iqvia has a lower price-to-earnings ratio than its industry peers. The p/e ratio is used to assess a company's market performance against aggregate data.
Benzinga · 5d ago
Weekly Report: what happened at IQV last week (1120-1124)?
Weekly Report · 11/27 09:18
More
About IQV
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Webull offers Iqvia Holdings Inc stock information, including NYSE: IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.